Balanced assessment of growth disorders using clinical, endocrinological, and genetic approaches

키워드

참고문헌 (62)

1. Hossain M, "Evidence-based approaches to childhood stunting in low and middle income countries : a systematic review", Arch Dis Child, 102, pp.903~909 (2017)
2. Noeker M, "Psychological functioning in idiopathic short stature", Horm Res Pediatr, 76(Suppl 3), pp.52~56 (2011)
3. Savage MO, "Early detection, referral, investigation, and diagnosis of children with growth disorders", Horm Res Pediatr, 85, pp.325~332 (2016)
4. Rapaport R, "Growth failure: ‘idiopathic’only after detailed investigation of short stature.’", Endocr Connect, 10, pp.R125~R138 (2021)
5. Baron J, "Short and tall stature : a new paradigm emerges", Nat Rev Endocrinol, 11, pp.735~746 (2015)
6. Wit JM, "Towards a rational and efficient diagnostic approach in children referred for growth failure to the general paediatrician", Horm Res Pediatr, 91, pp.223~240 (2019)
7. Hermanussen M, "The calculation of target height reconsidered", Horm Res, 59, pp.180~183 (2003)
8. Cohen P, "Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop", J Clin Endocrinol Metab, 93, pp.4210~4217 (2008)
9. Sisley S, "Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children", J Pediatr, 163, pp.1045~1051 (2013)
10. Dauber A, "Genetic testing for the child with short staturehas the time come to change our diagnostic paradigm", J Clin Endocrinol Metab, 104, pp.2766~2769 (2019)
11. Wit JM, "Idiopathic short stature : definition, epidemiology, and diagnostic evaluation", Growth Horm IGF Res, 18, pp.89~110 (2008)
12. Wit JM, "Mechanisms in endocrinology : novel genetic causes of short stature", Eur J Endocrinol, 174, pp.R145~R173 (2016)
13. Collett-Solberg PF, "Diagnosis, genetics, and therapy of short stature in children : a growth hormone research society international perspective", Horm Res Paediatr, 92, pp.1~14 (2019)
14. Graber E, "Growth and growth disorders in children and adolescents", Pediatr Ann, 41, pp.e1~e9 (2012)
15. Blum WF, "The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders", Endocr Connect, 7, pp.R212~R222 (2018)
16. Salmon WD, "A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro", J Lab Clin Med, 49, pp.825~836 (1957)
17. Kaplan SA, "The somatomedin hypothesis 2007 : 50 years later", J Clin Endocrinol Metab, 92, pp.4529~4535 (2007)
18. LeRoith D, "Clinical relevance of systemic and local IGF-I : lessons from animal models", Pediatr Endocrinol Rev, 5(Suppl 2), pp.739~743 (2008)
19. Ranke MB, "Defining insulin-like growth factor-I deficiency", Horm Res, 65(Suppl 1), pp.9~14 (2006)
20. Park P, "Insulin-like growth factor(IGF-I)measurements in growth hormone(GH)therapy of idiopathic short stature(ISS)", Growth Horm IGF Res, 15(Suppl A), pp.S13~S20 (2005)
21. Cohen P, "Insulin growth factor-based dosing of growth hormone therapy in children : a randomized, controlled study", J Clin Endocrinol Metab, 92, pp.2480~2486 (2007)
22. Selva KA, "Reproducibility in patterns of IGF generation with special reference to idiopathic short stature", Horm Res, 60, pp.237~246 (2003)
23. Buckway CK, "The IGF-I generation test revisited : a marker of GH sensitivity", J Clin Endocrinol Metab, 86, pp.5176~5183 (2001)
24. Wit JM, "A Proposal for the Interpretation of Serum IGF-I concentration as part of laboratory screening in children with growth failure", J Clin Res Pediatr Endocrinol, 12, pp.130~139 (2020)
25. Yau M, "Peak growth hormone response to combined stimulation test in 315 children and correlations with metabolic parameters", Horm Res Paediatr, 92, pp.36~44 (2019)
26. Coutant R, "Diagnosis of endocrine disease : limitations of the IGF1 generation test in children with short stature", Eur J Endocrinol, 166, pp.351~357 (2012)
27. Argente J, "Genetic causes of proportionate short stature", Best Pract Res Clin Endocrinol Metab, 32, pp.499~522 (2018)
28. Sjoberg M, "Study of GH sensitivity in Chilean patients with idiopathic short stature", J Clin Endocrinol Metab, 86, pp.4375~4381 (2001)
29. Storr HL, "Nonclassical GH insensitivity : characterization of mild abnormalities of GH action", Endocr Rev, 40, pp.476~505 (2019)
30. Vairamani K, "Novel dominant-negative gh receptor mutations expands the spectrum of GHI and IGF-I deficiency", J Endocr Soc, 1, pp.345~348 (2017)
31. Metherell LA, "Pseudoexon activation as a novel mechanism for disease resulting in atypical growthhormone insensitivity", Am J Hum Genet, 69, pp.641~646 (2001)
32. Klammt J, "Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation", Nat Commun, 9, pp.2105~ (2018)
33. Heath KE, "Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor(IGF)-I, IGF binding protein-3levels, and hyperinsulinemia", J Clin Endocrinol Metab, 93, pp.1616~1624 (2008)
34. Dauber A, "Mutations in pregnancyassociated plasma protein A2 cause short stature due to low IGF-I availability", EMBO Mol Med, 8, pp.363~374 (2016)
35. Fofanova-Gambetti OV, "Impact of heterozygosity for acidlabile subunit(IGFALS)gene mutations on stature : results from the international acid-labile subunit consortium", J Clin Endocrinol Metab, 95, pp.4184~4191 (2010)
36. Walenkamp MJE, "Phenotypic features and response to GH treatment of patients with a molecular defect of the IGF-1 receptor", J Clin Endocrinol Metab, 104, pp.3157~3171 (2019)
37. Begemann M, "Paternally inherited IGF2 mutation and growth restriction", N Engl J Med, 373, pp.349~356 (2015)
38. Finken MJJ, "Children born small for gestational age : differential diagnosis, molecular genetic evaluation, and implications", Endocr Rev, 39, pp.851~894 (2018)
39. Fukami M, "SHOX haploinsufficiency as a cause of syndromic and nonsyndromic short stature", Mol Syndromol, 7, pp.3~11 (2016)
40. Binder G, "Short stature due to SHOX deficiency : genotype, phenotype, and therapy", Horm Res Paediatr, 75, pp.81~89 (2011)
41. Benabbad I, "Safety outcomes and near-adult height gain of growth hormone-treated children with shox deficiency : data from an observational study and a clinical trial", Horm Res Paediatr, 87, pp.42~50 (2017)
42. Shapiro S, "SHOX gene variants : growth hormone", insulin-like growth factor-1 status and response to growth hormone treatment, 2015, pp.83, 26~35
43. Kant SG, "A novel variant of FGFR3 causes proportionate short stature", Eur J Endocrinol, 172, pp.763~770 (2015)
44. Pinto G, "Efficacy and safety of growth hormone treatment in children with hypochondroplasia : comparison with an historical cohort", Horm Res Paediatr, 82, pp.355~363 (2014)
45. Hisado-Oliva A, "Heterozygous NPR2 mutations cause disproportionate short stature, similar to Léri-Weill dyschondrosteosis", J Clin Endocrinol Metab, 100, pp.E1133~E1142 (2015)
46. Vasques GA, "Heterozygous mutations in natriuretic peptide receptor-B(NPR2)gene as a cause of short stature in patients initially classified as idiopathic short stature", J Clin Endocrinol Metab, 98, pp.E1636~E1644 (2013)
47. Wang SR, "Heterozygous mutations in natriuretic peptide receptor-B(NPR2)gene as a cause of short stature", Hum Mutat, 36, pp.474~481 (2015)
48. Nilsson O, "Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations", J Clin Endocrinol Metab, 99, pp.E1510~E1518 (2014)
49. Hauer NN, "Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature", Sci Rep, 7, pp.12225~ (2017)
50. Hauer NN, "Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature", Genet Med, 20, pp.630~638 (2018)
51. Dauber A, "Genetic evaluation of short stature", J Clin Endocrinol Metab, 99, pp.3080~3092 (2014)
52. Argente J, "Genetics of growth disorders-which patients require genetic testing?", Front Endocrinol (Lausanne), 10, pp.602~ (2019)
53. Murray PG, "A genetic approach to evaluation of short stature of undetermined cause", Lancet Diabetes Endocrinol, 6, pp.564~574 (2018)
54. Wang SR, "Large-scale pooled next-generation sequencing of 1077 genes to identify genetic causes of short stature", J Clin Endocrinol Metab, 98, pp.E1428~E1437 (2013)
55. Nilsson O, "Aggrecanopathies highlight the need for genetic evaluation of ISS children", Eur J Endocrinol, 183, pp.C9~C10 (2020)
56. Chatterjee S, "Phenotypic spectrum and responses to recombinant human IGF1(rhIGF1)therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation", Eur J Endocrinol, 178, pp.481~489 (2018)
57. Wakeling EL, "Diagnosis and management of Silver-Russell syndrome : first international consensus statement", Nat Rev Endocrinol, 13, pp.105~124 (2017)
58. Freire BL, "Multigene sequencing analysis of children born small for gestational age with isolated short stature", J Clin Endocrinol Metab, 104, pp.2023~2030 (2019)
59. Cottrell E, "The value of whole exome sequencing for genetic diagnosis in a patient with Bloom syndrome", J Endocrinol Invest, 44, pp.1331~1334 (2021)
60. Stalman SE, "Genetic analyses in smallfor-gestational-age newborns", J Clin Endocrinol Metab, 103, pp.917~925 (2018)
61. Howell SJ, "Growth hormone replacement and the risk of malignancy in children with neurofibromatosis", J Pediatr, 133, pp.201~205 (1998)
62. Noseworthy J, "The future of care-preserving the patientphysician relationship", N Engl J Med, 381, pp.2265~2269 (2019)

관련 논문AI추천